Topical Administration of Anti-Oxidant, OT-551 for the Treatment of Geographic Atrophy: Results of a Phase I/II Clinical Trial

被引:0
|
作者
Wong, W. T. [1 ]
Kam, W. [1 ]
Cunningham, D. [2 ]
Chew, E. Y. [1 ]
Ferris, F. L., III [3 ]
机构
[1] NEI, Unit Neuron Glia Interact Epidemiol & Clin Applic, Bethesda, MD 20892 USA
[2] NEI, Bethesda, MD 20892 USA
[3] NEI, NIH, Bethesda, MD 20892 USA
关键词
age-related macular degeneration; antioxidants; clinical (human) or epidemiologic studies: treatment/prevention assessment/controlled clinical trials;
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
6418
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Liposomal drug delivery system for anti-inflammatory treatment after cataract surgery: a phase I/II clinical trial
    Wong, Chee Wai
    Wong, Edmund
    Metselaar, Josbert M.
    Storm, Gert
    Wong, Tina T.
    DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2022, 12 (01) : 7 - 14
  • [33] Æ-941 (Neovastat), an inhibitor of angiogenesis:: Phase I/II lung cancer clinical trial results
    Riviere, M
    Latreille, J
    Falardeau, P
    Dupont, E
    ANNALS OF ONCOLOGY, 1998, 9 : 133 - 133
  • [34] Oral minocycline for the treatment of retinitis pigmentosa-associated cystoid macular edema: results of a phase I/II clinical trial
    Dave, Amisha D.
    Chen, Katherine G.
    Chiang, Trent Tsun-Kang
    Singaravelu, Janani
    Alvarez, Jason A.
    Wong, Wai T.
    Cukras, Catherine A.
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2023, 261 (08) : 2209 - 2220
  • [35] SUBCUTANEOUS ERYTHROPOIETIN FOR TREATMENT OF REFRACTORY-ANEMIA IN HEMATOLOGIC DISORDERS - RESULTS OF A PHASE-I/II CLINICAL-TRIAL
    CAZZOLA, M
    PONCHIO, L
    BEGUIN, Y
    ROSTI, V
    BERGAMASCHI, G
    LIBERATO, NL
    FREGONI, V
    NALLI, G
    BAROSI, G
    ASCARI, E
    BLOOD, 1992, 79 (01) : 29 - 37
  • [36] Treatment of inoperable pancreatic carcinoma using a cell-based local chemotherapy:: results of a phase I/II clinical trial
    Salmons, B
    Löhr, M
    Günzburg, WH
    JOURNAL OF GASTROENTEROLOGY, 2003, 38 : 78 - 84
  • [37] Intrathecal Administration of Autologous Mesenchymal Stem Cells in Multiple System Atrophy - A Phase I/II Dose-Escalation Trial
    Singer, Wolfgang
    Dietz, Allan
    Zeller, Anita
    Gehrking, Tonette
    Schmelzer, James
    Sletten, David
    Gehrking, Jade
    Coon, Elizabeth
    Sandroni, Paola
    Benarroch, Eduardo
    Fealey, Robert
    Matsumoto, Joseph
    Bower, James
    Ahlskog, J.
    Hassan, Anhar
    McKeon, Andrew
    Klassen, Bryan
    Low, Phillip
    NEUROLOGY, 2017, 88
  • [38] Intrathecal administration of autologous mesenchymal stem cells in multiple system atrophy - a phase I/II dose-escalation trial
    Singer, W.
    Dietz, A.
    Zeller, A.
    Gehrking, T.
    Schmelzer, J.
    Sletten, D.
    Gehrking, J.
    Coon, E.
    Sandroni, P.
    Benarroch, E.
    Fealey, R.
    Matsumoto, J.
    Bower, J.
    Ahlskog, J.
    Hassan, A.
    McKeon, A.
    Klassen, B.
    Low, P.
    MOVEMENT DISORDERS, 2017, 32
  • [39] TREAT-ME 1: Treatment of advanced gastrointestinal cancer in a clinical phase I/II trial with genetically modified mesenchymal stem cells: Clinical results of a phase I study
    von Einem, Jobst C.
    Niess, Hanno
    Michl, Marlies
    Nelson, Peter J.
    Scherhammer, Volker
    Guenther, Christine
    Salat, Christoph
    Stoetzer, Oliver J.
    Angele, Martin K.
    Bruns, Christiane J.
    Heinemann, Volker
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [40] Clinical Evaluation of Dendritic Cell Vaccination for Patients with Recurrent Glioma: Results of a Clinical Phase I/II Trial
    Yamanaka, Ryuya
    Homma, Junpei
    Yajima, Naoki
    Sano, Masakazu
    Takahashi, Masuhiro
    MOLECULAR THERAPY, 2006, 13 : S106 - S106